Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial.

Autor: Gabriel R; Departamento de Salud Internacional, Escuela Nacional de Sanidad, Instituto de Salud Carlos III, 28029 Madrid, Spain.; World Community for Prevention of Diabetes Foundation (WCPD), 28001 Madrid, Spain.; Asociación para la Investigación y Prevención de la Diabetes y Enfermedades Cardiovasculares (PREDICOR), 28001 Madrid, Spain., Boukichou-Abdelkader N; Asociación para la Investigación y Prevención de la Diabetes y Enfermedades Cardiovasculares (PREDICOR), 28001 Madrid, Spain.; EVIDEM CONSULTORES, 28030 Madrid, Spain., Gilis-Januszewska A; Department of Endocrinology, Jagiellonian University Medical College, 31-008 Krakow, Poland., Makrilakis K; Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Gómez-Huelgas R; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), 29018 Málaga, Spain., Kamenov Z; Clinic of Endocrinology, University Multi-Profile Hospital for Active Treatment Alexandrovska EAD, Medical University of Sofia, 1431 Sofia, Bulgaria., Paulweber B; Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft (SALK), 5020 Salzburg, Austria., Satman I; Division of Endocrinology & Metabolism, Department of Internal Medicine, Istanbul University, 34093 Istanbul, Turkey., Djordjevic P; General Hospital Medical System Beograd-MSB, 11010 Belgrade, Serbia., Alkandari A; Dasman Diabetes Research Institute, Kuwait City 15462, Kuwait., Mitrakou A; Alexandra Hospital, University of Athens, 11635 Athens, Greece., Lalic N; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Egido J; Renal, Vascular and Diabetes Research Laboratory, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma, 28040 Madrid, Spain., Más-Fontao S; Renal, Vascular and Diabetes Research Laboratory, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma, 28040 Madrid, Spain., Calvet JH; IMPETO Medical, 92130 Paris, France., Pastor JC; Instituto Universitario de Oftalmobiología Aplicada (IOBA), Hospital Clínico Universitario, Universidad de Valladolid, 47011 Valladolid, Spain., Lindström J; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland., Lind M; Department of Molecular and Clinical Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden.; Department of Medicine, NU-Hospital Group, 451 53 Uddevalla, Sweden.; Department of Internal Medicine, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden., Acosta T; Department of Public Health, Universidad del Norte, Barranquilla 080001, Colombia., Silva L; EVIDEM CONSULTORES, 28030 Madrid, Spain., Tuomilehto J; Departamento de Salud Internacional, Escuela Nacional de Sanidad, Instituto de Salud Carlos III, 28029 Madrid, Spain.; World Community for Prevention of Diabetes Foundation (WCPD), 28001 Madrid, Spain.; Asociación para la Investigación y Prevención de la Diabetes y Enfermedades Cardiovasculares (PREDICOR), 28001 Madrid, Spain.; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.; Department of Public Health, University of Helsinki, 00014 Helsinki, Finland.; Diabetes Research Group, King Abdulaziz University, Jeddah 21589, Saudi Arabia., On Behalf Of The E-Predice Consortium

Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Mar 03; Vol. 12 (5). Date of Electronic Publication: 2023 Mar 03.

Sudomotor dysfunction in patients recovered from COVID-19.

Autor: Hinduja A; Aarti Clinic, Kharghar, Navi Mumbai, India. Electronic address: dranand01@gmail.com., Moutairou A; Impeto Medical, Paris, France., Calvet JH; Impeto Medical, Paris, France.

Publikováno v: Neurophysiologie clinique = Clinical neurophysiology [Neurophysiol Clin] 2021 Mar; Vol. 51 (2), pp. 193-196. Date of Electronic Publication: 2021 Jan 26.

Airway epithelial damage and release of inflammatory mediators in human lung parenchyma after sulfur mustard exposure

Autor: Calvet Jh, Delamanche S, Gascard Jp, Brink C

Publikováno v: Human & Experimental Toxicology. 18:77-81

This study was performed to evaluate the morphological effects of sulfur mustard on human lung parenchyma in vitro and to measure the metabolites of arachidonic acid which are released during acute exposure to the alkylating agent. Histological analy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c035398996be404a76d34a85df1a69a
https://doi.org/10.1177/096032719901800203

Douleur neuropathique associée à la Covid-19 : revue systématique et méta-analyse *.

Autor: Di Stefano, G.¹ (AUTHOR), Falco, P.¹ (AUTHOR), Galosi, E.¹ (AUTHOR), Di Pietro, G.¹ (AUTHOR), Leone, C.¹ (AUTHOR), Truini, A.¹ (AUTHOR) andrea.truini@uniroma1.it

Publikováno v: Douleur et Analgésie. jui-sep 2024, Vol. 37 Issue 3, p181-190. 10p.

Airway epithelial damage induced by sulfur mustard in uinea pigs, effects of glucocorticoids.

Autor: Calvet, JH, Coste, A., Levame, M., Harf, A., Macquin-Mavier, I., Escudier, E.

Publikováno v: Human & Experimental Toxicology; Dec1996, Vol. 15 Issue 12, p964-971, 8p